Tower Research Capital LLC (Trc) Mesoblast LTD Transaction History

Tower Research Capital LLC (Trc)

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 10, 2023	SELL	$2.73 - $3.7 $513 - $695	-188 Reduced 6.79%	2,582 $8,000
Q3 2022 Nov 10, 2022	BUY	$0.48 - $3.48 $1,329 - $9,639	2,770 New	2,770 $7,000
Q1 2022 May 12, 2022	SELL	$3.58 - $4.98 $10,034 - $13,958	-2,803 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$4.17 - $7.09 $11,688 - $19,873	2,803 New	2,803 $13,000
Q3 2021 Nov 15, 2021	SELL	$5.87 - $7.85 $28,569 - $38,205	-4,867 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$6.69 - $9.0 $29,449 - $39,618	4,402 Added 946.67%	4,867 $36,000
Q1 2021 May 17, 2021	BUY	$8.26 - $11.4 $3,840 - $5,301	465 New	465 $4,000

151K

Ticker MESO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 147,316,000
Market Cap $2.51B
Description
Mesoblast Limited, a biopharmaceutical company, develops and commercializes allogeneic cellular medicines in the United States, Australia, Singapore, the United Kingdom, and Switzerland. The company offers products in the areas of cardiovascular, spine orthopedic disorder, oncology, hematology, and immune-mediated and inflammatory diseases. Its ...

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.